跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
Approved
STANDARD
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9a1dd6cd93f8a8ad
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
9a1dd6cd93f8a8ad
Product Name
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
Artg Id
414649
Artg Name
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2024-08-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2235426bf075f8a9b034fb4f68ed6340.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/59eeae051615757b017ba8665c834bd8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9a1dd6cd93f8a8ad
Type
Standard
Back to TGA Approvals